Author:
Jia Jia,Zhang Guochao,Wei LuoPei,Qi Linlin,Wang Xiaojun,Li Lin,Zeng Hua,Wang Jianwei,Xue Qi,Ying Jianming,Xue Liyan
Funder
Beijing Hope Run Special Fund of Cancer Foundation of China
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Travis WD, Brambilla E, Burke A, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th edn. Lyon: International Agency for Research on Cancer; 2015.
2. Borczuk AC, Cooper WA, Dacic S, et al. WHO Classification of tumours pathology and genetics of tumours of the lung, pleura, thymus and heart. 5th edn. World Health Organization; 2021.
3. Moreira AL, Ocampo PS, Xia Y, Zhong H, Mino-Kenudson M. A grading system for invasive pulmonary adenocarcinoma: a proposal from the iaslc pathology committee. Journal of Thoracic Oncology. 2020;15(10):1599–610.
4. Gow CH, Hsieh MS, Liu YN, Lee YH, Shih JY. Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma. Cancers (Basel). 2021;13(16):4103.
5. Chang WC, Zhang YZ, Lim E, Nicholson AG. Prognostic impact of histopathologic features in pulmonary invasive mucinous adenocarcinomas. Am J Clin Pathol. 2020;154(1):88–102.